Bio-Techne (TECH) reported fiscal Q2 adjusted earnings Wednesday of $0.42 per diluted share, up from $0.40 a year earlier.
Analysts polled by FactSet expected $0.39.
Net sales for the quarter ended Dec. 31 were $297 million, up from $272.6 million a year earlier.
Analysts surveyed by FactSet expected $285.8 million.
The company's shares were up nearly 6% in recent premarket activity.
Price: 76.79, Change: +4.24, Percent Change: +5.8
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。